Statewide
Montana Board of Medical Examiners
The current listed document is more than 24 months old and may be outdated.
Drugs and doses30
A–C Albuterol, Aspirin, Atropine3
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 2.5 mg | NEB | not captured | standing | pages 22, 23 · source |
| Anaphylaxis | peds | 2.5 mg | NEB | not captured | standing | pages 22, 23 · source |
| Respiratory distress | adult | 2.5 mg | NEB | not captured | standing | pages 44, 64, 78 · source |
| Respiratory distress | peds | 2.5 mg | NEB | not captured | standing | pages 44, 64, 78 · source |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 325 mg | PO | not captured | standing | page 35 · source |
D–F Dexamethasone, Dextrose, Diazepam, Diphenhydramine, Dopamine, Epinephrine, Fentanyl7
Dexamethasone
Dextrose
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5 mg | IV | not captured | standing | page 27 · source |
| Mild to moderate pain | adult | 5 mg | IV | not captured | standing | page 63 · source |
| Seizure | adult | 2–10 mg | IV/IO/ET | not captured | standing | page 72 · source |
| Seizure | peds | 0.3 mg/kg (max 10 mg) | IV/IO/ET | not captured | standing | page 72 · source |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 50 mg | IV/IM | not captured | standing | page 27 · source |
| Anaphylaxis | adult | 50 mg | IM | not captured | standing | page 23 · source |
| Anaphylaxis | adult | 50 mg | IV | not captured | standing | pages 23, 24 · source |
| Anaphylaxis | adult | 50–100 mg | PO | not captured | standing | pages 22, 23 · source |
| Anaphylaxis | peds | 0.5–1 mg/kg (max 50 mg) | PO | not captured | standing | pages 22, 23 · source |
| Anaphylaxis | peds | 0.5–1 mg/kg (max 50 mg) | IM | not captured | standing | page 23 · source |
| Anaphylaxis | peds | 0.5–1 mg/kg (max 50 mg) | IV | not captured | standing | pages 23, 24 · source |
Dopamine
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | pages 22, 23 · source |
| Anaphylaxis | peds | 0.01 mg/kg (max 0.5 mg) | IM | not captured | standing | pages 22, 23 · source |
| Anaphylaxis | peds | 0.1 mL/kg (max 4 mL) | IV | not captured | standing | page 23 · source |
| Neonatal resuscitation | peds | 0.01–0.03 mg/kg | IV/IO/IM/ET | not captured | standing | page 59 · source |
| Respiratory distress | adult | 0.3–0.5 mg | IM | not captured | standing | pages 44, 64 · source |
| Respiratory distress | peds | 0.5 mg | NEB | not captured | standing | page 64 · source |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 25–50 mcg | IV/IO | not captured | standing | page 52 · source |
| Mild to moderate pain | adult | 25–50 mcg | IV/IO/IM/IN | not captured | standing | pages 62, 63 · source |
| Mild to moderate pain | peds | 0.5 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 62, 63 · source |
G–L Glucagon, Haloperidol, Hydrocortisone, Hydromorphone, Hydroxocobalamin, Ipratropium, Ketamine, Lidocaine, Lorazepam9
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 mg | IM/IN/SQ | not captured | standing | pages 19, 40 · source |
| Hypoglycemia | adult | 1 mg | IM/IN | not captured | standing | pages 19, 27, 38, 40, 43, 71, 73 · source |
| Hypoglycemia | peds | 0.5 mg | IM/IN | not captured | standing | pages 19, 27, 38, 40, 43, 71, 73 · source |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5 mg | IV/IM | not captured | standing | page 27 · source |
Hydrocortisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 100 mg | IM | not captured | standing | page 16 · source |
| Adrenal crisis | adult | 100 mg | IV/IO/IM | not captured | standing | page 16 · source |
| Adrenal crisis | peds | 2 mg/kg | IM | not captured | standing | page 16 · source |
| Adrenal crisis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 16 · source |
Hydromorphone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.5–1 mg | IV/IO/IM | not captured | standing | page 63 · source |
Hydroxocobalamin
Ipratropium
Ketamine
Lidocaine
M–O Magnesium Sulfate, Methylprednisolone, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Oxytocin8
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Seizure | adult | 4 g | IV | not captured | standing | page 60 · source |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 125 mg | IM | not captured | standing | page 16 · source |
| Adrenal crisis | adult | 125 mg | IV/IO/IM | not captured | standing | page 16 · source |
| Adrenal crisis | peds | 2 mg/kg | IM | not captured | standing | page 16 · source |
| Adrenal crisis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 16 · source |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg | IV/IO/IN | not captured | standing | pages 28, 29 · source |
| Agitation | adult | 2–4 mg | IV/IM | not captured | standing | page 27 · source |
| Mild to moderate pain | adult | 2–4 mg | IV/IM | not captured | standing | page 63 · source |
| Seizure | peds | 0.2 mg/kg (max 5 mg) | IV/IM/IN | not captured | standing | page 72 · source |
Morphine
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.4 mg | IM/IN | not captured | standing | page 19 · source |
| Other | adult | 0.4–4 mg | IN | not captured | standing | pages 18, 42 · source |
| Other | adult | 0.4–4 mg | IV/IO/IM/IN/ET | not captured | standing | pages 19, 20, 43 · source |
| Other | adult | 0.4–4 mg | IV/IM/IN/ET | not captured | standing | page 19 · source |
| Other | peds | 0.1 mg/kg | IV/IO/IM/IN/ET | not captured | standing | pages 19, 20, 43 · source |
| Other | peds | 0.1 mg/kg | IV/IM/IN/ET | not captured | standing | page 19 · source |
| Other | peds | 0.2 mg/kg | IN | not captured | standing | pages 18, 42 · source |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 35 · source |
Norepinephrine
Oxytocin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Obstetric hemorrhage | adult | 20 unit | IV | not captured | standing | page 60 · source |
S–Z Sodium Bicarbonate, Thiamine, Tranexamic Acid3
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Tricyclic overdose | adult | 1 mEq/kg | IV | not captured | standing | page 43 · source |
Thiamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 100 mg | IV | not captured | standing | pages 19, 43, 71 · source |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 1 g | IV | not captured | standing | page 56 · source |
Cite this
Montana Board of Medical Examiners, United States EMS Protocol Census. 81 dose entries, effective 2020-11-01.
https://protoquiz.com/census/agencies/montana-board-of-medical-examiners/
The census is free and not for sale. Only public agencies are named.